MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Naltrexone Treatment for Alcoholic Women

Phase 4
Completed
Conditions
Alcoholism
Eating Disorder
Interventions
Drug: Placebo
First Posted Date
1999-11-03
Last Posted Date
2014-05-07
Lead Sponsor
Yale University
Target Recruit Count
160
Registration Number
NCT00000448
Locations
🇺🇸

Substance Abuse Treatment Unit, Yale University, New Haven, Connecticut, United States

Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)

Phase 2
Completed
Conditions
Alcoholism
Alcohol Dependence
Interventions
First Posted Date
1999-11-03
Last Posted Date
2013-01-29
Lead Sponsor
Yale University
Target Recruit Count
198
Registration Number
NCT00000451

Smoking Cessation in Alcoholism Treatment

Phase 4
Completed
Conditions
Alcoholism
Smoking
First Posted Date
1999-11-03
Last Posted Date
2010-05-19
Lead Sponsor
Yale University
Target Recruit Count
112
Registration Number
NCT00000454
Locations
🇺🇸

Substance Abuse Treatment Center, VA Medical Center, West Haven, Connecticut, United States

Neurobiology of Opioid Dependence: 1 - 1

Phase 2
Withdrawn
Conditions
Opioid-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2015-08-07
Lead Sponsor
Yale University
Registration Number
NCT00000192
Locations
🇺🇸

VA Connecticut Healthcare System, New Haven, Connecticut, United States

Neurobiology of Opioid Dependence: 5 - 5

Phase 2
Withdrawn
Conditions
Opioid-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2015-06-03
Lead Sponsor
Yale University
Registration Number
NCT00000196
Locations
🇺🇸

VA Connecticut Healthcare System, New Haven, Connecticut, United States

Rapid Benzodiazepine Detoxification Using Flumazenil - 1

Phase 2
Completed
Conditions
Substance-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2016-09-08
Lead Sponsor
Yale University
Target Recruit Count
10
Registration Number
NCT00000246
Locations
🇺🇸

Yale University, Psychiatry, New Haven, Connecticut, United States

Buprenorphine Maintenance for Opioid Addicts - 2

Phase 2
Completed
Conditions
Opioid-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2020-04-29
Lead Sponsor
Yale University
Registration Number
NCT00000203
Locations
🇺🇸

VA Connecticut Healthcare System, New Haven, Connecticut, United States

Glutaminergic Agents for Cocaine Abuse - 5

Phase 1
Completed
Conditions
Cocaine-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2017-04-25
Lead Sponsor
Yale University
Registration Number
NCT00000280
Locations
🇺🇸

VA Connecticut Healthcare System, New Haven, Connecticut, United States

Neurobiology of Opioid Dependence: 4 - 4

Phase 2
Withdrawn
Conditions
Opioid-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2016-05-06
Lead Sponsor
Yale University
Registration Number
NCT00000195
Locations
🇺🇸

VA Connecticut Healthcare System, New Haven, Connecticut, United States

Buprenorphine Maintenance for Opioid Addicts - 1

Phase 2
Completed
Conditions
Opioid-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2020-04-29
Lead Sponsor
Yale University
Registration Number
NCT00000202
Locations
🇺🇸

VA Connecticut Healthcare System, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath